iDtheinvestordatabase
Home / Directory / Mérieux Equity Partners
Active: last investment listed 2026 Verified 7 Nov 2026

Mérieux Equity Partners

Lyon and Paris based healthcare and nutrition investor with two platforms: a buyout team for profitable companies and an Innovation (venture capital) team that leads or co-leads seed to Series B rounds in European medtech, biotech and digital health companies.

Type
Fund manager
Location
Lyon, France
Stages
Seed, Series A, Series B
Sectors
Healthtech and life sciences, Biotech, Medtech, Nutrition
Fund size / AUM
Mérieux Innovation 2 (2025) targeting EUR 150m; OMX Europe Venture Fund (2020) EUR 117m; buyout fund MP5 first close EUR 335m (own site)

Contacts on file

For Mérieux Equity Partners, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); check size; LinkedIn page.

Get Europe Complete, $99 Free sample

One-time payment. No subscription. No account.

Notable investments

HighLife MedicalOna TherapeuticsHealth in CodeSwixx Biopharma

Sources

Last checked 7 Nov 2026. Is something wrong? Tell us.

Appears in 23 lists